Annual Total Liabilities
$33.26 M
+$253.20 K+0.77%
December 31, 2023
Summary
- As of February 8, 2025, PDSB annual total liabilities is $33.26 million, with the most recent change of +$253.20 thousand (+0.77%) on December 31, 2023.
- During the last 3 years, PDSB annual total liabilities has risen by +$29.50 million (+784.36%).
- PDSB annual total liabilities is now -25.56% below its all-time high of $44.68 million, reached on December 31, 2014.
Performance
PDSB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$30.45 M
+$871.70 K+2.95%
September 30, 2024
Summary
- As of February 8, 2025, PDSB quarterly total liabilities is $30.45 million, with the most recent change of +$871.70 thousand (+2.95%) on September 30, 2024.
- Over the past year, PDSB quarterly total liabilities has dropped by -$2.81 million (-8.45%).
- PDSB quarterly total liabilities is now -72.10% below its all-time high of $109.13 million, reached on September 30, 2015.
Performance
PDSB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PDSB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.8% | -8.4% |
| 3 y3 years | +784.4% | -2.8% |
| 5 y5 years | +421.2% | -2.8% |
PDSB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +734.1% | -8.4% | +663.6% |
| 5 y | 5-year | at high | +1090.6% | -8.4% | +990.0% |
| alltime | all time | -25.6% | +1090.6% | -72.1% | +990.0% |
PDS Biotechnology Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $30.45 M(+2.9%) |
| Jun 2024 | - | $29.58 M(-7.1%) |
| Mar 2024 | - | $31.82 M(-4.3%) |
| Dec 2023 | $33.26 M(+0.8%) | $33.26 M(+1.7%) |
| Sep 2023 | - | $32.70 M(+4.5%) |
| Jun 2023 | - | $31.31 M(+14.1%) |
| Mar 2023 | - | $27.44 M(-16.9%) |
| Dec 2022 | $33.01 M(+727.7%) | $33.01 M(+18.6%) |
| Sep 2022 | - | $27.83 M(+508.2%) |
| Jun 2022 | - | $4.58 M(-11.4%) |
| Mar 2022 | - | $5.17 M(+29.5%) |
| Dec 2021 | $3.99 M(+6.0%) | $3.99 M(+2.5%) |
| Sep 2021 | - | $3.89 M(-11.5%) |
| Jun 2021 | - | $4.40 M(+29.8%) |
| Mar 2021 | - | $3.39 M(-9.9%) |
| Dec 2020 | $3.76 M(+34.6%) | $3.76 M(+10.0%) |
| Sep 2020 | - | $3.42 M(+11.1%) |
| Jun 2020 | - | $3.08 M(-23.9%) |
| Mar 2020 | - | $4.05 M(+44.9%) |
| Dec 2019 | $2.79 M | $2.79 M(-26.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $3.80 M(-26.9%) |
| Jun 2019 | - | $5.20 M(-21.2%) |
| Mar 2019 | - | $6.60 M(+3.4%) |
| Dec 2018 | $6.38 M(-78.9%) | $6.38 M(-4.6%) |
| Sep 2018 | - | $6.69 M(-51.8%) |
| Jun 2018 | - | $13.87 M(-57.1%) |
| Mar 2018 | - | $32.33 M(+6.9%) |
| Dec 2017 | $30.25 M(+39.8%) | $30.25 M(+13.8%) |
| Sep 2017 | - | $26.59 M(-7.4%) |
| Jun 2017 | - | $28.72 M(+35.1%) |
| Mar 2017 | - | $21.25 M(-1.8%) |
| Dec 2016 | $21.64 M(+86.3%) | $21.64 M(+13.5%) |
| Sep 2016 | - | $19.07 M(+120.1%) |
| Jun 2016 | - | $8.66 M(-4.2%) |
| Mar 2016 | - | $9.04 M(-22.1%) |
| Dec 2015 | $11.62 M(-74.0%) | $11.62 M(-89.4%) |
| Sep 2015 | - | $109.13 M(+934.8%) |
| Jun 2015 | - | $10.55 M(-76.4%) |
| Dec 2014 | $44.68 M(+85.5%) | $44.68 M |
| Dec 2013 | $24.08 M | - |
FAQ
- What is PDS Biotechnology annual total liabilities?
- What is the all time high annual total liabilities for PDS Biotechnology?
- What is PDS Biotechnology annual total liabilities year-on-year change?
- What is PDS Biotechnology quarterly total liabilities?
- What is the all time high quarterly total liabilities for PDS Biotechnology?
- What is PDS Biotechnology quarterly total liabilities year-on-year change?
What is PDS Biotechnology annual total liabilities?
The current annual total liabilities of PDSB is $33.26 M
What is the all time high annual total liabilities for PDS Biotechnology?
PDS Biotechnology all-time high annual total liabilities is $44.68 M
What is PDS Biotechnology annual total liabilities year-on-year change?
Over the past year, PDSB annual total liabilities has changed by +$253.20 K (+0.77%)
What is PDS Biotechnology quarterly total liabilities?
The current quarterly total liabilities of PDSB is $30.45 M
What is the all time high quarterly total liabilities for PDS Biotechnology?
PDS Biotechnology all-time high quarterly total liabilities is $109.13 M
What is PDS Biotechnology quarterly total liabilities year-on-year change?
Over the past year, PDSB quarterly total liabilities has changed by -$2.81 M (-8.45%)